Slocum, Gordon & Co
ABBV icon

Slocum, Gordon & Co’s AbbVie ABBV Stock Holding History

Slocum, Gordon & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.26M Sell
20,100
-87
-0.4% -$22.3K 3.67% 7
2026
Q2 		$5.08M Sell
20,187
-280
-1% -$60.2K 3.37% 8
2026
Q1 		$4.45M Sell
20,467
-555
-3% -$123K 3.03% 10
2025
Q4 		$4.8M Sell
21,022
-87
-0.4% -$19.8K 3.48% 9
2025
Q3 		$4.89M Sell
21,109
-37
-0.2% -$7.54K 3.9% 9
2025
Q2 		$3.93M Sell
21,146
-254
-1% -$47.2K 3.16% 11
2025
Q1 		$4.48M Sell
21,400
-16,917
-44% -$3.29M 3.34% 11
2024
Q4 		$6.81M Sell
38,317
-1,857
-5% -$341K 5.6% 5
2024
Q3 		$7.93M Sell
40,174
-2,282
-5% -$426K 3.19% 9
2024
Q2 		$7.28M Sell
42,456
-58
-0.1% -$9.6K 5.42% 6
2024
Q1 		$7.74M Sell
42,514
-30
-0.1% -$5.17K 5.75% 5
2023
Q4 		$6.59M Buy
42,544
+250
+0.6% +$36.4K 5.79% 5
2023
Q3 		$6.3M Sell
42,294
-850
-2% -$125K 5.49% 5
2023
Q2 		$5.81M Sell
43,144
-260
-0.6% -$38.1K 4.22% 10
2023
Q1 		$6.92M Sell
43,404
-12,850
-23% -$1.96M 5.74% 6
2022
Q4 		$9.09M Buy
+56,254
New +$8.63M 5.86% 6

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Slocum, Gordon & Co's ABBV Position: Q3 2026 in Review

Slocum, Gordon & Co reduced its AbbVie (ABBV) stake by 0.43% in Q3 2026, selling an estimated $22.3K and leaving 20,100 shares worth $5.26M. The position accounts for 3.67% of the portfolio, ranked #7.

Slocum, Gordon & Co first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. The position peaked at $9.09M in Q4 2022. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Slocum, Gordon & Co held 20,100 shares of AbbVie worth $5.26M as of Q3 2026.
  • Slocum, Gordon & Co sold 87 AbbVie shares in Q3 2026, an estimated $22.3K.
  • AbbVie made up 3.67% of Slocum, Gordon & Co's portfolio in Q3 2026, its #7 holding.
  • Slocum, Gordon & Co first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
  • Slocum, Gordon & Co's AbbVie position peaked at $9.09M in Q4 2022.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Slocum, Gordon & Co's 13F filing for Q3 2026, filed 19 Oct 2026.